Prospective, Multicenter, Randomized, Double-Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Novel Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin
Neuromodulation Technology at the Neural Interface2016Vol. 19(1), pp. 91–100
Citations Over TimeTop 1% of 2016 papers
Timothy R. Deer, Jason E. Pope, Ramsin Benyamin, Ricardo Vallejo, Andrew S. Friedman, David Caraway, Peter S. Staats, Eric Grigsby, W. Porter McRoberts, Tory McJunkin, Richard Shubin, Payam Vahedifar, Daryoush Tavanaiepour, Robert M. Levy, Leonardo Kapural, Nagy Mekhail
Related Papers
- → Neuropathic pain in patients with sickle cell disease(2013)112 cited
- → Silencing of lncRNA PKIA-AS1 Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain Through Epigenetic Downregulation of CDK6 Expression(2019)33 cited
- → MicroRNA‐144 relieves chronic constriction injury‐induced neuropathic pain via targeting RASA1(2019)28 cited
- → Can the Neuropathic Pain Scale Discriminate Between Non-neuropathic and Neuropathic Pain?(2008)45 cited
- → Loss of SNHG4 Attenuated Spinal Nerve Ligation-Triggered Neuropathic Pain through Sponging miR-423-5p(2020)17 cited